Single Cell Analysis Market Research Report Information By Product (Consumables and Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry and Others), By End-User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, and Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Ma

Global Single Cell Analysis Market Overview

Single Cell Analysis Market Size was valued at USD 3.3 Billion in 2022. The Single-Cell Analysis market industry is projected to grow from USD 3.82 Billion in 2023 to USD 12.36 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.80% during the forecast period (2023 - 2032). Increasing incidence of cancer and scientific progress are the key market drivers boosting the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Single Cell Analysis Market Trends

• Growing rates of cancer incidence are driving the market growth

Market CAGR for single-cell analysis is being driven by the fact that cancer rates are rising all around the world because of factors like an aging population and poor dietary and exercise habits. Single-cell RNA sequencing has also been used in cancer research to monitor tumor growth, detect cells with abnormal gene expression, and stop the spread of malignant neoplasms at an early stage. The increasing incidence of cancer is the primary cause propelling this industry forward. Potential market growth drivers include factors including fast urbanization and digitization, improved healthcare infrastructure, and rising levels of awareness.

Additionally, due to innovations in single-cell analysis technology and rising investments in research and development within the pharmaceutical and biotechnology sectors, the single-cell analysis market is expected to expand at a rapid clip worldwide over the next few years. The expanding fields of stem cell study and customized therapy, as well as the ever-increasing rates of cancer incidence and mortality, all contribute to the expansion of the single-cell analysis industry.

However, it is expected that the high price of single-cell analysis solutions will slow the expansion of the market. On the other hand, the single-cell analysis market projection indicates that the significant growth potential of single-cell sequencing would present attractive growth prospects for the dominant player in the market. Moreover, the rising R&D spending in the pharmaceutical and biotechnology sectors is expected to create attractive opportunities for the demand for single-cell analysis tools. The introduction of technology in single-cell amplification and manipulation techniques leading to the application of high throughput technologies in assays, as well as the increase in investments and government funds deployed in the field of medical diagnostics, will further provide numerous growth opportunities for the market.

For instance, Mission Bio, Inc. has introduced its Tapestry Solution for Solid Tumor Studies. A new nuclei isolation prep process and glioblastoma multiforme, an enhanced single-cell copy number variation bioinformatics analysis tool are all part of this comprehensive single-cell DNA sequencing workflow on the Tapestri Platform. As a result, it is expected that throughout the projection period, demand for single-cell analysis is due to the increasing rate of cancer incidence. Thus driving the single-cell analysis market revenue.

Single Cell Analysis Market Segment Insights

Single Cell Analysis Product Insights

The single-cell analysis market segmentation, based on product, includes consumables and instruments. The consumables segment dominated the market because the rising incidence of target diseases, the ongoing demand for assay consumables, and the widespread applicability of the products themselves all contribute to this trend.

Figure 1:  Single Cell Analysis Market, by Product, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Single Cell Analysis Techniques Insights

The single-cell analysis market segmentation, based on techniques, includes flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), mass spectrometry, and others. In 2022, the next-generation sequencing (NGS) segment sector held the highest market share ly, accounting for over 65.62% of the total revenue because of the rise in genome mapping studies, an increase in next-generation sequencing applications, rising healthcare costs, and improved sequencing platform technology.

Single Cell Analysis End User Insights

The single-cell analysis market segmentation, based on end users, includes academic & research laboratories, biotechnology & pharmaceutical companies, and others. In 2022, the worldwide single-cell analysis market share was dominated by the biotechnology & pharmaceutical companies category because single-cell analysis has become more widely used by the biotechnology and pharmaceutical industries as a result of technological advancements such as the usage of microfluidics in the creation of next-generation treatments.

Single Cell Analysis Application Insights

The single-cell analysis market segmentation, based on application, includes oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization (IVF), and others. The oncology segment dominated the market because of the rising incidence of cancer. The expansion of this market is also attributable to the fact that single-cell analysis has been shown to be useful in the past for diagnosing cancer cells.

Single Cell Analysis Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American single-cell analysis market area will dominate this market, owing to improved healthcare infrastructure, the growing elderly population, and positive reimbursement policies in the healthcare sector.

Further, the major countries studied in the market report are The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2:  SINGLE CELL ANALYSIS MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe’s single-cell analysis market accounts for the second-largest market share because of the increasing need for personalized treatment, which can be traced to a number of causes, including expanding possibilities in cancer cell research and rising consumer awareness of medical technology advancements. Further, the German single-cell analysis market held the largest market share, and the UK single-cell analysis market was the fastest-growing market in the European region.

The Asia-Pacific single-cell analysis Market is predicted to grow at the highest CAGR from 2023 to 2032. This is due to rising businesses like biotechnology and pharmaceuticals, as well as rising collaborations between major players and technical developments. The single-cell analysis industry in the region has been expanding rapidly in recent years, thanks in large part to a number of government initiatives. Moreover, China’s single-cell analysis market held the largest market share, and the Indian single-cell analysis market was the fastest-growing market in the Asia-Pacific region.

Single Cell Analysis Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the single-cell analysis market grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the single-cell analysis industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the single-cell analysis industry to benefit clients and increase the market sector. In recent years, the single-cell analysis industry has offered some of the most significant advantages to medicine. Major players in the single-cell analysis market, including DOLOMITE BIO, Becton, Dickinson and Company, DIASORIN GROUP (LUMINEX CORPORATION), Merck KGaA, BGI GENOMICS CO. LTD, Danaher Corporation, Thermo Fisher Scientific, Inc., BERKLEY LIGHTS INC, TAKARA HOLDINGS INC, OXFORD NANAOPORE TECHNOLOGIES, STANDARD BIOTOOLS (Fluidigm Corporation), Illumina, Inc., Sartorius AG, QIAGEN N.V, Agilent Technologies, Inc., 10x Genomics, and Bio-Rad Laboratories.

Dolomite Bio offers customers cutting-edge tools for high throughput single-cell research that help them overcome the difficulties of biological research. Our devices make it possible to quickly analyze tens of thousands or millions of individual cells and the natural products they produce by encapsulating each one in a microfluidic droplet. In April 2022, Dolomite Bio released new hydrogel-focused reagent kits that make it possible to encapsulate cells in hydrogel scaffolds at high throughput. Researchers interested in agarose encapsulation and collagen-based hydrogel projects for 3D cell culture can use the nadAROSE and nadia3D kits to meet their demands. There are currently few commercially accessible solutions and expensive, time-consuming, "home brew" batch methods used to create hydrogel scaffolds. Dolomite Bio is releasing the nadAROSE kit for the encapsulation of cells in agarose, as well as the nadia3D kit for research into 3D cell culture as a result.

Merck is a well-known scientific and technological business that works in the fields of electronics, healthcare, and life sciences. By developing more happy and sustainable lifestyle options, more than 64,000 professionals strive to impact millions of people's lives every day positively. The company is widely recognized for its ability to create and manufacture drugs more quickly, find novel approaches to treating the most difficult ailments, and empower gadgets with intelligence. In June 2023, Merck announced an expansion of its facility in Lenexa, Kansas, making it the company's largest dry powder cell culture media facility and Center of Excellence in North America. Expand capabilities with new lab space and 9,100 sq m of additional manufacturing space.

Key Companies in the Single Cell Analysis market include

• DOLOMITE BIO


• Becton Dickinson & Company


• DIASORIN GROUP (LUMINEX CORPORATION)


• Merck KGaA


• BGI GENOMICS CO. LTD


• Danaher Corporation


• Thermo Fisher Scientific Inc.


• BERKLEY LIGHTS INC


• TAKARA HOLDINGS INC


• OXFORD NANOPORE TECHNOLOGIES


• STANDARD BIOTOOLS (Fluidigm Corporation)


• Illumina Inc.


• Sartorius AG


• QIAGEN N.V


• Agilent Technologies Inc.


• 10x Genomics


• Bio-Rad Laboratories

Single Cell Analysis Industry Developments

January 2022: Oxford Nanopore Technologies and bioMérieux SA launched a collaboration aimed at improving health outcomes worldwide through the investigation of certain prospects for introducing nanopore sequencing to the infectious disease diagnostics industry.

March 2022: 10x Genomics has released new solutions with the goal of increasing the number of customers using its state-of-the-art Chromium platform for single-cell analysis and reducing the time spent on sample preparation.

Single Cell Analysis Market Segmentation

Single Cell Analysis Product Outlook

• Consumables


• Instruments

Single Cell Analysis Techniques Outlook

• Flow Cytometry


• Next Generation Sequencing (NGS)


• Polymerase Chain Reaction (PCR)


• Mass Spectrometry


• Others

Single Cell Analysis End User Outlook

• Academic & Research Laboratories


• Biotechnology & Pharmaceutical Companies


• Others

Single Cell Analysis Application Outlook

• Oncology


• Immunology


• Neurology


• Stem cell


• Non-Invasive Prenatal Diagnosis


• In-vitro fertilization (IVF)


• Others

Single Cell Analysis Regional Outlook

• North America

• 
  
  
  
  • US
  
  
  • Canada
  
  
  
  

• Europe

• 
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  

• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World

• 
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America